chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Head injury, Loss of consciousness, Urinary incontinence, Vomiting
Clinical narrative: Pt received vaccine and stood up roughly 1 minute after vaccination and passed out. she hit her head on the plexiglass and then hit her head on the floor, lost consciousness, used smelling salt to wake her up. Patient woke up and begin to vomit. lost consciousness again, used ice packs on back of neck and forehead. Cold compresses on cheeks. Pt lost control of bladder and urinated. Pt came to after about 15 minutes after - was under supervision of two pharmacists for the entirety of the full 15 minutes. Pt went with EMS.
Age: 64.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site bruising, Injection site haemorrhage, Injection site pain
Clinical narrative: At time of injection, there was a drip of blood when needle removed.  Bleeding stopped with single cotton ball and bandaid.  Patient states the area began to bruise later and it has taken weeks to fully resolve.  States it has remained slightly tender to touch.  No loss of ability to use arm fully as usual reported by patient.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, Death, Dyspnoea, Endotracheal intubation
Clinical narrative: pt diagnosed positive for COVID on 8/14/21 by PCP; presents to ED with c/o increasing SOB and decreased O2 sats (76% on NRB); hx of COPD, multiple myloma; treated with antibiotics, steroids, anticoagulants, remdisivir; placed on BiPAP; eventually required intubation due to worsening condition; family decided on comfort care measures; pt was extubated and died at the hosp
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Positive airway pressure therapy, SARS-CoV-2 test positive
Clinical narrative: pt diagnosed positive for COVID on 8/14/21 by PCP; presents to ED with c/o increasing SOB and decreased O2 sats (76% on NRB); hx of COPD, multiple myloma; treated with antibiotics, steroids, anticoagulants, remdisivir; placed on BiPAP; eventually required intubation due to worsening condition; family decided on comfort care measures; pt was extubated and died at the hosp
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered, Fatigue, Headache, Pain
Clinical narrative: vaccine expired on 11/1/21. Dose administered on 11/5/21 (4 days past expiration date) She reported symptoms much like 1st dose, night of vaccine she was fatigued, day after vaccine developed headache, body aches. All symptoms were resolved by day 2 after vaccine
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine expired on 11/1/21. Dose administered on 11/5/21 (4 days past expiration date) She reported symptoms much like 1st dose, night of vaccine she was fatigued, day after vaccine developed headache, body aches. All symptoms were resolved by day 2 after vaccine
Age: 84.0
Sex: F
Vaccine: PNC13
Symptoms: Extra dose administered
Clinical narrative: Patient stated her dr wanted her to get a pneumonia shot, stated she couldn't remember her last pneumonia shot. We looked at STC and IRIS no record on either. She stated it had been 10-15 years since last. Thus thought received Pneumo23.  We called dr Monday to see if she had record  of the a shot. They stated she got Prevnair 13 in 2013, thus this was her second.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Administered .5 ml instead of .25 ml for booster dose.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Chills, Dizziness, Fatigue, Injection site pain
Clinical narrative: I took my Covid booster shot at around 2:30 on thursday afternoon(Nov 4th). About 10 hours later, I felt extremely dizzy. The dizziness continued the whole of the next day where I was unable to get out of bed. The vertigo (dizziness) was accompanied with vomiting every time I stood up to go to the bathroom. I was unable to keep down any food or water for the entire next day. I am an otherwise healthy person but I needed physical help to get to the bathroom all of friday. On saturday, the nausea went away but the vertigo persisted mildly. It is now Monday and I am still feeling tired and not back to my usual self. In addition to the vertigo and nausea, I did have fever, chills, injection site pain and body aches. The most debilitating symptom was the vertigo and nausea. My husband informed the primary care doctor about the reaction and they wanted me to get admitted in the hospital for IV fluids. But, we decided against it due to my physical inability to get out of bed.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia, Vertigo, Vomiting
Clinical narrative: I took my Covid booster shot at around 2:30 on thursday afternoon(Nov 4th). About 10 hours later, I felt extremely dizzy. The dizziness continued the whole of the next day where I was unable to get out of bed. The vertigo (dizziness) was accompanied with vomiting every time I stood up to go to the bathroom. I was unable to keep down any food or water for the entire next day. I am an otherwise healthy person but I needed physical help to get to the bathroom all of friday. On saturday, the nausea went away but the vertigo persisted mildly. It is now Monday and I am still feeling tired and not back to my usual self. In addition to the vertigo and nausea, I did have fever, chills, injection site pain and body aches. The most debilitating symptom was the vertigo and nausea. My husband informed the primary care doctor about the reaction and they wanted me to get admitted in the hospital for IV fluids. But, we decided against it due to my physical inability to get out of bed.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Vaccine Administration Error with No Adverse Event Reported by Patient  Patient was scheduled to receive their second dose of the Moderna COVID-19 vaccine (0.5ML) and instead received a Moderna COVID-19 booster dose (0.25ML).  Patient is deciding whether or not they want to receive additional vaccine to equal the "full" 0.5ML dose.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine was given to patient after the 30 days in refrigerator had already passed.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Administered .5 ml instead of .25 ml for booster dose.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Ataxia, Chest pain, Computerised tomogram head normal, Condition aggravated, Depression
Clinical narrative: Recently now has ataxia with migraines, also now has substernal squeezing chest pain (random, non-constant, and non-radiating) which lasts several hours, whole body shakes for a few minutes, depression, and suicidal ideation. This is her second hospitalization within the past two weeks.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging, Magnetic resonance imaging head abnormal, Migraine, Suicidal ideation, Tremor
Clinical narrative: Recently now has ataxia with migraines, also now has substernal squeezing chest pain (random, non-constant, and non-radiating) which lasts several hours, whole body shakes for a few minutes, depression, and suicidal ideation. This is her second hospitalization within the past two weeks.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: White matter lesion
Clinical narrative: Recently now has ataxia with migraines, also now has substernal squeezing chest pain (random, non-constant, and non-radiating) which lasts several hours, whole body shakes for a few minutes, depression, and suicidal ideation. This is her second hospitalization within the past two weeks.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested PCR positive for COVID 11/6/21 after being fully vaccinated.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood urine present, Cardiac stress test normal, Chest X-ray normal, Chest discomfort, Computerised tomogram normal
Clinical narrative: In late July I started having shortness of breath and tight chest on the hot humid days.  My PCP referred me to a cardiologist in September.  The cardiologist ordered a stress test for Oct 4 2021. But on Oct 3 2021 I was urinating blood and went to the ER. The ER put me on 3L of oxygen because they saw my oxygen level drop on the pulse-ox.  I was admitted from Oct 4 2021 to Oct 8 2021.  I had a stress test,  echocardigram,  CT SCAN,  lab work,  chest x-ray and all test seemed to come back ok. I was walked by the nurse with a pulse-ox on and within 30 feet my oxygen level dropped from 97 to 82 so a lung Dr was called in.  She ordered a pulmonary function test,  blood gas test and a echocardigram bubble study.   I was discharged on Oct 8 2021 with oxygen to have at home.  I was sent to a facility for a possible pulmonary avm.  But at that visit that Dr did he did not believe that was evident and would refer us back to the initial pulmonary Dr to do a heart catheter test and a test to sample fluid in my lung.  I have not been able to work.  And was healthy before my vaccines.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Dyspnoea exertional, Echocardiogram normal, Impaired work ability, Laboratory test normal
Clinical narrative: In late July I started having shortness of breath and tight chest on the hot humid days.  My PCP referred me to a cardiologist in September.  The cardiologist ordered a stress test for Oct 4 2021. But on Oct 3 2021 I was urinating blood and went to the ER. The ER put me on 3L of oxygen because they saw my oxygen level drop on the pulse-ox.  I was admitted from Oct 4 2021 to Oct 8 2021.  I had a stress test,  echocardigram,  CT SCAN,  lab work,  chest x-ray and all test seemed to come back ok. I was walked by the nurse with a pulse-ox on and within 30 feet my oxygen level dropped from 97 to 82 so a lung Dr was called in.  She ordered a pulmonary function test,  blood gas test and a echocardigram bubble study.   I was discharged on Oct 8 2021 with oxygen to have at home.  I was sent to a facility for a possible pulmonary avm.  But at that visit that Dr did he did not believe that was evident and would refer us back to the initial pulmonary Dr to do a heart catheter test and a test to sample fluid in my lung.  I have not been able to work.  And was healthy before my vaccines.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Oxygen saturation decreased
Clinical narrative: In late July I started having shortness of breath and tight chest on the hot humid days.  My PCP referred me to a cardiologist in September.  The cardiologist ordered a stress test for Oct 4 2021. But on Oct 3 2021 I was urinating blood and went to the ER. The ER put me on 3L of oxygen because they saw my oxygen level drop on the pulse-ox.  I was admitted from Oct 4 2021 to Oct 8 2021.  I had a stress test,  echocardigram,  CT SCAN,  lab work,  chest x-ray and all test seemed to come back ok. I was walked by the nurse with a pulse-ox on and within 30 feet my oxygen level dropped from 97 to 82 so a lung Dr was called in.  She ordered a pulmonary function test,  blood gas test and a echocardigram bubble study.   I was discharged on Oct 8 2021 with oxygen to have at home.  I was sent to a facility for a possible pulmonary avm.  But at that visit that Dr did he did not believe that was evident and would refer us back to the initial pulmonary Dr to do a heart catheter test and a test to sample fluid in my lung.  I have not been able to work.  And was healthy before my vaccines.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Pain, Pyrexia, Respiratory tract congestion
Clinical narrative: cough, fever, congestion, body aches. starting on 11/6/21
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: 12 year old eligible for full dose of pfizer vaccine dose one received pediatric dose one.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Administered .5 ml instead of .25 ml for booster dose.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Heart rate increased, Lethargy
Clinical narrative: Patient dizzy, lethargic and heart rate elevated (109) after receiving covid vaccine. BP 149/75 and BS 122. Provider assessed and monitored in exam for about 45 minutes. Patient discharged in stable condition.
Age: 2.0
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Injection site erythema
Clinical narrative: Redness around injection site.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dyspnoea
Clinical narrative: Patient was having shortness of breath on 11/6/21 and went to emergency room where he passed away.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Blood magnesium, Chest X-ray, Chest pain, Computerised tomogram thorax abnormal
Clinical narrative: Tachycardia a consistent heart rate of 90 to 120 bpm with a resting heart rate of 79 bpm. Flushing/red check. High blood pressure, chest pain, back pain.   Follow up with Cardiologist December 20th 2021
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Culture urine, Differential white blood cell count, Electrocardiogram, Erythema, Flushing
Clinical narrative: Tachycardia a consistent heart rate of 90 to 120 bpm with a resting heart rate of 79 bpm. Flushing/red check. High blood pressure, chest pain, back pain.   Follow up with Cardiologist December 20th 2021
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Full blood count, Human chorionic gonadotropin, Hypertension, Metabolic function test, Pulmonary embolism
Clinical narrative: Tachycardia a consistent heart rate of 90 to 120 bpm with a resting heart rate of 79 bpm. Flushing/red check. High blood pressure, chest pain, back pain.   Follow up with Cardiologist December 20th 2021
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Scan with contrast abnormal, Tachycardia, Troponin, Urine analysis
Clinical narrative: Tachycardia a consistent heart rate of 90 to 120 bpm with a resting heart rate of 79 bpm. Flushing/red check. High blood pressure, chest pain, back pain.   Follow up with Cardiologist December 20th 2021
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Gait disturbance, Tremor
Clinical narrative: client was verbalizing anxiousness prior to vaccination and stated that client stated "feeling dizzy" while walking to the observation room post vaccination. Co Lead rn observed client to be visibly shaking and gripping boyfriend's hand with both of her hands. Client was A&Ox2 to person and situation. Co Lead RN determined client could not ambulate towards observation room and went to retrieve wheelchair. Client was safely transferred into wheelchair with two nurse assist and then taken to observation room. Secondary RN set up gravity chair in observation room for client. Client then transferred into gravity chair from wheelchair with two nurse assist. Co Lead RN recommended for client to lower her face mask and take long deep breaths. At 11:15 AM first vitals taken on client: BP LA 170/100, pulse 78, O2 SAT 98%. Client stated, "I am diagnosed with anxiety by a doctor and take anxiety medications for it. Last time I was this anxious around needles was about 3 months ago. I always begin to feel short of breath." Client was unable to remember her medication name. Client stated, "I forgot to take my anxiety medication today, I have the medication bottle in my car." Client was provided water to drink but declined snacks. Co Lead RN observed client to become more relaxed and was answering questions with smiling and giggling throughout conversation. Client stated, "I am starting to feel better" and was now observed to be A&Ox4. Co Lead RN educated client to follow up with primary care physician. Boyfriend confirmed that he would be driving both of them home. Co Lead RN stated to client to continue taking deep breaths and relax for another 15 minutes. At 11:36 second set of vitals: BP LA 132/88, Pulse 68, O2 SAT 98%. Secondary RN educated client on the importance of taking anxiety medication before any procedure she knows that would trigger an episode and to have them on her person. Client verbalized understanding and then stated, "I am ready to go home now." Co Lead RN walked as standby assist with client as she walked with a steady gait (boyfriend at her side) outside the facility at 11:42 AM.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Administered .5 ml instead of .25 ml for booster dose.
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient hospitalized with a positive COVID-19 test
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Headache, Nausea, Pyrexia, Tendonitis
Clinical narrative: 1st shot - developed tendonitis in both wrists which continues today 2nd shot - Severe nausea, severe headache and fatigue for 24 hours, severe tendonitis continues 3rd shot - Severe nausea, severe headache, fatigue, fever for 48 hours, fatigue continues today as does severe tendonitis requiring occupational therapy
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient given vaccine after 30 day passed in the refrigerator .
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Impaired work ability, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Patient reports that since her 2nd dose of Pfizer on 1/8/21, she has had chronic fatigue, on and off daily fevers, and brain fog. Patient has been evaluated by PCP but no explanation provided.  Patient has never tested positive for COVID. Reports that her symptoms are very different than those caused by menopause which she has had for a few years already. Patient has called off work several times due to her symptoms.
Age: 15.0
Sex: M
Vaccine: FLU4
Symptoms: Dyspnoea, Pharyngeal swelling
Clinical narrative: Swelling in throat and difficulty breathing. Called 911 and administered Epipen 0.3mg , patient feeling better by the time the EMT arrived. Patient was taken to hospital for further evaluation and treatment.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Alanine aminotransferase normal, Anion gap, Aspartate aminotransferase normal
Clinical narrative: 69 year old man with history of ESRD due to DM, s/p renal transplant 9/12, post transplant lymphoproliferative disorder (diffuse large B cell lymphoma) in 2016, s/p chemo and maintenance rituxan, type 2 DM, chronic kidney disease with baseline cr 1.4-1.6, right common iliac artery aneurysm who presents with weakness found to have +covid. Pt admitted for covid pneumonia, acute hypoxemic respiratory failure.  1.) covid pneumonia, acute hypoxemic respiratory failure- pt received pfizer vaccine and booster 10/7;  Symptoms started 10/20, tested + at facility 10/23. Pt reportedly received monoclonal ab (regereron while at facility ); pt signed out AMA and presented to ED with weakness and hypoxia. Pt started on remdesivir and decadron. He felt much better on 10/25; denies shortness of breath and able to ambulate in room without hypoxia. US was done to rule out DVT. No evid of DVT. No symptoms to suggest PE and given AKI and improved hypoxia, will not do CT angio chest. Since clinically improving and no longer hypoxic, will plan dc home today.   2.) history of renal transplant- present with AKI; holding cozaar; cr improving. Renal US without hydro; will cont to hold cozaar on dc   3.) elevated trop I- suspect demand ischemia from covid/ AKI; peak trop is 0.06;    4.) DM, hypertension- resume home meds but will hold cozaar   Primary Procedures:  CXR US renal   Secondary Procedures: US LE doppler   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia, acute hypoxemic respiratory failure
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Atelectasis, Basophil percentage decreased, Blood alkaline phosphatase normal, Blood bilirubin normal
Clinical narrative: 69 year old man with history of ESRD due to DM, s/p renal transplant 9/12, post transplant lymphoproliferative disorder (diffuse large B cell lymphoma) in 2016, s/p chemo and maintenance rituxan, type 2 DM, chronic kidney disease with baseline cr 1.4-1.6, right common iliac artery aneurysm who presents with weakness found to have +covid. Pt admitted for covid pneumonia, acute hypoxemic respiratory failure.  1.) covid pneumonia, acute hypoxemic respiratory failure- pt received pfizer vaccine and booster 10/7;  Symptoms started 10/20, tested + at facility 10/23. Pt reportedly received monoclonal ab (regereron while at facility ); pt signed out AMA and presented to ED with weakness and hypoxia. Pt started on remdesivir and decadron. He felt much better on 10/25; denies shortness of breath and able to ambulate in room without hypoxia. US was done to rule out DVT. No evid of DVT. No symptoms to suggest PE and given AKI and improved hypoxia, will not do CT angio chest. Since clinically improving and no longer hypoxic, will plan dc home today.   2.) history of renal transplant- present with AKI; holding cozaar; cr improving. Renal US without hydro; will cont to hold cozaar on dc   3.) elevated trop I- suspect demand ischemia from covid/ AKI; peak trop is 0.06;    4.) DM, hypertension- resume home meds but will hold cozaar   Primary Procedures:  CXR US renal   Secondary Procedures: US LE doppler   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia, acute hypoxemic respiratory failure
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Blood calcium decreased, Blood chloride decreased, Blood creatinine increased, Blood culture, Blood glucose increased
Clinical narrative: 69 year old man with history of ESRD due to DM, s/p renal transplant 9/12, post transplant lymphoproliferative disorder (diffuse large B cell lymphoma) in 2016, s/p chemo and maintenance rituxan, type 2 DM, chronic kidney disease with baseline cr 1.4-1.6, right common iliac artery aneurysm who presents with weakness found to have +covid. Pt admitted for covid pneumonia, acute hypoxemic respiratory failure.  1.) covid pneumonia, acute hypoxemic respiratory failure- pt received pfizer vaccine and booster 10/7;  Symptoms started 10/20, tested + at facility 10/23. Pt reportedly received monoclonal ab (regereron while at facility ); pt signed out AMA and presented to ED with weakness and hypoxia. Pt started on remdesivir and decadron. He felt much better on 10/25; denies shortness of breath and able to ambulate in room without hypoxia. US was done to rule out DVT. No evid of DVT. No symptoms to suggest PE and given AKI and improved hypoxia, will not do CT angio chest. Since clinically improving and no longer hypoxic, will plan dc home today.   2.) history of renal transplant- present with AKI; holding cozaar; cr improving. Renal US without hydro; will cont to hold cozaar on dc   3.) elevated trop I- suspect demand ischemia from covid/ AKI; peak trop is 0.06;    4.) DM, hypertension- resume home meds but will hold cozaar   Primary Procedures:  CXR US renal   Secondary Procedures: US LE doppler   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia, acute hypoxemic respiratory failure
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactic acid, Blood magnesium increased, Blood phosphorus normal, Blood potassium normal, Blood sodium decreased
Clinical narrative: 69 year old man with history of ESRD due to DM, s/p renal transplant 9/12, post transplant lymphoproliferative disorder (diffuse large B cell lymphoma) in 2016, s/p chemo and maintenance rituxan, type 2 DM, chronic kidney disease with baseline cr 1.4-1.6, right common iliac artery aneurysm who presents with weakness found to have +covid. Pt admitted for covid pneumonia, acute hypoxemic respiratory failure.  1.) covid pneumonia, acute hypoxemic respiratory failure- pt received pfizer vaccine and booster 10/7;  Symptoms started 10/20, tested + at facility 10/23. Pt reportedly received monoclonal ab (regereron while at facility ); pt signed out AMA and presented to ED with weakness and hypoxia. Pt started on remdesivir and decadron. He felt much better on 10/25; denies shortness of breath and able to ambulate in room without hypoxia. US was done to rule out DVT. No evid of DVT. No symptoms to suggest PE and given AKI and improved hypoxia, will not do CT angio chest. Since clinically improving and no longer hypoxic, will plan dc home today.   2.) history of renal transplant- present with AKI; holding cozaar; cr improving. Renal US without hydro; will cont to hold cozaar on dc   3.) elevated trop I- suspect demand ischemia from covid/ AKI; peak trop is 0.06;    4.) DM, hypertension- resume home meds but will hold cozaar   Primary Procedures:  CXR US renal   Secondary Procedures: US LE doppler   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia, acute hypoxemic respiratory failure
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Blood urea increased, Brain natriuretic peptide normal, C-reactive protein increased, COVID-19, COVID-19 pneumonia
Clinical narrative: 69 year old man with history of ESRD due to DM, s/p renal transplant 9/12, post transplant lymphoproliferative disorder (diffuse large B cell lymphoma) in 2016, s/p chemo and maintenance rituxan, type 2 DM, chronic kidney disease with baseline cr 1.4-1.6, right common iliac artery aneurysm who presents with weakness found to have +covid. Pt admitted for covid pneumonia, acute hypoxemic respiratory failure.  1.) covid pneumonia, acute hypoxemic respiratory failure- pt received pfizer vaccine and booster 10/7;  Symptoms started 10/20, tested + at facility 10/23. Pt reportedly received monoclonal ab (regereron while at facility ); pt signed out AMA and presented to ED with weakness and hypoxia. Pt started on remdesivir and decadron. He felt much better on 10/25; denies shortness of breath and able to ambulate in room without hypoxia. US was done to rule out DVT. No evid of DVT. No symptoms to suggest PE and given AKI and improved hypoxia, will not do CT angio chest. Since clinically improving and no longer hypoxic, will plan dc home today.   2.) history of renal transplant- present with AKI; holding cozaar; cr improving. Renal US without hydro; will cont to hold cozaar on dc   3.) elevated trop I- suspect demand ischemia from covid/ AKI; peak trop is 0.06;    4.) DM, hypertension- resume home meds but will hold cozaar   Primary Procedures:  CXR US renal   Secondary Procedures: US LE doppler   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia, acute hypoxemic respiratory failure
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Carbon dioxide normal, Chest X-ray abnormal, Chest pain, Eosinophil percentage decreased, Fibrin D dimer
Clinical narrative: 69 year old man with history of ESRD due to DM, s/p renal transplant 9/12, post transplant lymphoproliferative disorder (diffuse large B cell lymphoma) in 2016, s/p chemo and maintenance rituxan, type 2 DM, chronic kidney disease with baseline cr 1.4-1.6, right common iliac artery aneurysm who presents with weakness found to have +covid. Pt admitted for covid pneumonia, acute hypoxemic respiratory failure.  1.) covid pneumonia, acute hypoxemic respiratory failure- pt received pfizer vaccine and booster 10/7;  Symptoms started 10/20, tested + at facility 10/23. Pt reportedly received monoclonal ab (regereron while at facility ); pt signed out AMA and presented to ED with weakness and hypoxia. Pt started on remdesivir and decadron. He felt much better on 10/25; denies shortness of breath and able to ambulate in room without hypoxia. US was done to rule out DVT. No evid of DVT. No symptoms to suggest PE and given AKI and improved hypoxia, will not do CT angio chest. Since clinically improving and no longer hypoxic, will plan dc home today.   2.) history of renal transplant- present with AKI; holding cozaar; cr improving. Renal US without hydro; will cont to hold cozaar on dc   3.) elevated trop I- suspect demand ischemia from covid/ AKI; peak trop is 0.06;    4.) DM, hypertension- resume home meds but will hold cozaar   Primary Procedures:  CXR US renal   Secondary Procedures: US LE doppler   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia, acute hypoxemic respiratory failure
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Glomerular filtration rate decreased, Haematocrit decreased, Haemoglobin decreased, Hypoxia, Immature granulocyte count
Clinical narrative: 69 year old man with history of ESRD due to DM, s/p renal transplant 9/12, post transplant lymphoproliferative disorder (diffuse large B cell lymphoma) in 2016, s/p chemo and maintenance rituxan, type 2 DM, chronic kidney disease with baseline cr 1.4-1.6, right common iliac artery aneurysm who presents with weakness found to have +covid. Pt admitted for covid pneumonia, acute hypoxemic respiratory failure.  1.) covid pneumonia, acute hypoxemic respiratory failure- pt received pfizer vaccine and booster 10/7;  Symptoms started 10/20, tested + at facility 10/23. Pt reportedly received monoclonal ab (regereron while at facility ); pt signed out AMA and presented to ED with weakness and hypoxia. Pt started on remdesivir and decadron. He felt much better on 10/25; denies shortness of breath and able to ambulate in room without hypoxia. US was done to rule out DVT. No evid of DVT. No symptoms to suggest PE and given AKI and improved hypoxia, will not do CT angio chest. Since clinically improving and no longer hypoxic, will plan dc home today.   2.) history of renal transplant- present with AKI; holding cozaar; cr improving. Renal US without hydro; will cont to hold cozaar on dc   3.) elevated trop I- suspect demand ischemia from covid/ AKI; peak trop is 0.06;    4.) DM, hypertension- resume home meds but will hold cozaar   Primary Procedures:  CXR US renal   Secondary Procedures: US LE doppler   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia, acute hypoxemic respiratory failure
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza A virus test negative, Influenza B virus test, Lipase normal, Lung infiltration, Lymphocyte percentage
Clinical narrative: 69 year old man with history of ESRD due to DM, s/p renal transplant 9/12, post transplant lymphoproliferative disorder (diffuse large B cell lymphoma) in 2016, s/p chemo and maintenance rituxan, type 2 DM, chronic kidney disease with baseline cr 1.4-1.6, right common iliac artery aneurysm who presents with weakness found to have +covid. Pt admitted for covid pneumonia, acute hypoxemic respiratory failure.  1.) covid pneumonia, acute hypoxemic respiratory failure- pt received pfizer vaccine and booster 10/7;  Symptoms started 10/20, tested + at facility 10/23. Pt reportedly received monoclonal ab (regereron while at facility ); pt signed out AMA and presented to ED with weakness and hypoxia. Pt started on remdesivir and decadron. He felt much better on 10/25; denies shortness of breath and able to ambulate in room without hypoxia. US was done to rule out DVT. No evid of DVT. No symptoms to suggest PE and given AKI and improved hypoxia, will not do CT angio chest. Since clinically improving and no longer hypoxic, will plan dc home today.   2.) history of renal transplant- present with AKI; holding cozaar; cr improving. Renal US without hydro; will cont to hold cozaar on dc   3.) elevated trop I- suspect demand ischemia from covid/ AKI; peak trop is 0.06;    4.) DM, hypertension- resume home meds but will hold cozaar   Primary Procedures:  CXR US renal   Secondary Procedures: US LE doppler   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia, acute hypoxemic respiratory failure
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Mean cell volume normal, Monocyte percentage increased, Myocardial ischaemia, Neutrophil count, Neutrophil percentage
Clinical narrative: 69 year old man with history of ESRD due to DM, s/p renal transplant 9/12, post transplant lymphoproliferative disorder (diffuse large B cell lymphoma) in 2016, s/p chemo and maintenance rituxan, type 2 DM, chronic kidney disease with baseline cr 1.4-1.6, right common iliac artery aneurysm who presents with weakness found to have +covid. Pt admitted for covid pneumonia, acute hypoxemic respiratory failure.  1.) covid pneumonia, acute hypoxemic respiratory failure- pt received pfizer vaccine and booster 10/7;  Symptoms started 10/20, tested + at facility 10/23. Pt reportedly received monoclonal ab (regereron while at facility ); pt signed out AMA and presented to ED with weakness and hypoxia. Pt started on remdesivir and decadron. He felt much better on 10/25; denies shortness of breath and able to ambulate in room without hypoxia. US was done to rule out DVT. No evid of DVT. No symptoms to suggest PE and given AKI and improved hypoxia, will not do CT angio chest. Since clinically improving and no longer hypoxic, will plan dc home today.   2.) history of renal transplant- present with AKI; holding cozaar; cr improving. Renal US without hydro; will cont to hold cozaar on dc   3.) elevated trop I- suspect demand ischemia from covid/ AKI; peak trop is 0.06;    4.) DM, hypertension- resume home meds but will hold cozaar   Primary Procedures:  CXR US renal   Secondary Procedures: US LE doppler   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia, acute hypoxemic respiratory failure
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Platelet count normal, Red blood cell count decreased, Red blood cell nucleated morphology, Red cell distribution width increased, Respiratory syncytial virus test negative
Clinical narrative: 69 year old man with history of ESRD due to DM, s/p renal transplant 9/12, post transplant lymphoproliferative disorder (diffuse large B cell lymphoma) in 2016, s/p chemo and maintenance rituxan, type 2 DM, chronic kidney disease with baseline cr 1.4-1.6, right common iliac artery aneurysm who presents with weakness found to have +covid. Pt admitted for covid pneumonia, acute hypoxemic respiratory failure.  1.) covid pneumonia, acute hypoxemic respiratory failure- pt received pfizer vaccine and booster 10/7;  Symptoms started 10/20, tested + at facility 10/23. Pt reportedly received monoclonal ab (regereron while at facility ); pt signed out AMA and presented to ED with weakness and hypoxia. Pt started on remdesivir and decadron. He felt much better on 10/25; denies shortness of breath and able to ambulate in room without hypoxia. US was done to rule out DVT. No evid of DVT. No symptoms to suggest PE and given AKI and improved hypoxia, will not do CT angio chest. Since clinically improving and no longer hypoxic, will plan dc home today.   2.) history of renal transplant- present with AKI; holding cozaar; cr improving. Renal US without hydro; will cont to hold cozaar on dc   3.) elevated trop I- suspect demand ischemia from covid/ AKI; peak trop is 0.06;    4.) DM, hypertension- resume home meds but will hold cozaar   Primary Procedures:  CXR US renal   Secondary Procedures: US LE doppler   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia, acute hypoxemic respiratory failure
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Troponin I increased, Ultrasound Doppler normal, Ultrasound kidney, White blood cell count normal
Clinical narrative: 69 year old man with history of ESRD due to DM, s/p renal transplant 9/12, post transplant lymphoproliferative disorder (diffuse large B cell lymphoma) in 2016, s/p chemo and maintenance rituxan, type 2 DM, chronic kidney disease with baseline cr 1.4-1.6, right common iliac artery aneurysm who presents with weakness found to have +covid. Pt admitted for covid pneumonia, acute hypoxemic respiratory failure.  1.) covid pneumonia, acute hypoxemic respiratory failure- pt received pfizer vaccine and booster 10/7;  Symptoms started 10/20, tested + at facility 10/23. Pt reportedly received monoclonal ab (regereron while at facility ); pt signed out AMA and presented to ED with weakness and hypoxia. Pt started on remdesivir and decadron. He felt much better on 10/25; denies shortness of breath and able to ambulate in room without hypoxia. US was done to rule out DVT. No evid of DVT. No symptoms to suggest PE and given AKI and improved hypoxia, will not do CT angio chest. Since clinically improving and no longer hypoxic, will plan dc home today.   2.) history of renal transplant- present with AKI; holding cozaar; cr improving. Renal US without hydro; will cont to hold cozaar on dc   3.) elevated trop I- suspect demand ischemia from covid/ AKI; peak trop is 0.06;    4.) DM, hypertension- resume home meds but will hold cozaar   Primary Procedures:  CXR US renal   Secondary Procedures: US LE doppler   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia, acute hypoxemic respiratory failure
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Back pain, Computerised tomogram, Full blood count, Gastrooesophageal reflux disease
Clinical narrative: Had severe upper abdominal pain, back pain, fever, vomiting, acid reflux. Diagnosed with acute pancreatitis 3 days after symptoms started
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Lipase, Pancreatitis acute, Pyrexia, Scan with contrast, Vomiting
Clinical narrative: Had severe upper abdominal pain, back pain, fever, vomiting, acid reflux. Diagnosed with acute pancreatitis 3 days after symptoms started
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus
Clinical narrative: Started with mild itching Wednesday evening into Thursday.  Intensified Friday evening (11/5/21).   Hands, torso, feet.  Patient noticed some  slight swelling in hands/feet.  No hives/no rash. Symptoms come and go.  Still occurring, but at the present time of report.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine expired on 11/1/21. administered 11/5/21. Reported no side effects after vaccine
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine expired on 11/1/21. administered 11/5/21. Reported no side effects after vaccine
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Extrasystoles, Fatigue, Headache, Sleep disorder
Clinical narrative: Headache Aching joints  Awoken with Tachycardia  (150 bpm on pulseometer) in middle of night with Ectopic heart beats Extreme fatigue following day and unusual fatigue for a week
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: Headache Aching joints  Awoken with Tachycardia  (150 bpm on pulseometer) in middle of night with Ectopic heart beats Extreme fatigue following day and unusual fatigue for a week
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Blood cholesterol increased, Blood test, Chest X-ray normal, Condition aggravated, Electrocardiogram normal
Clinical narrative: I wasn't feeling good and went to the doctor on the 4th. She gave me Lisinopril 10 mg for High Blood Pressure. I've had other issues in the past with off and on High Blood Pressure. But not as high as this, 150/100. On the 5th, 169/11, blood pressure reading midday. My Blood Pressure it's still high. In the late evenings it's down to closer to where it should be but when I wake up it's high again. I'm feeling better though. I did have a flu shot around 10/1/2021. I had it at the local pharmacy.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Hypertension
Clinical narrative: I wasn't feeling good and went to the doctor on the 4th. She gave me Lisinopril 10 mg for High Blood Pressure. I've had other issues in the past with off and on High Blood Pressure. But not as high as this, 150/100. On the 5th, 169/11, blood pressure reading midday. My Blood Pressure it's still high. In the late evenings it's down to closer to where it should be but when I wake up it's high again. I'm feeling better though. I did have a flu shot around 10/1/2021. I had it at the local pharmacy.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood creatine phosphokinase increased, Blood urine present, Fluid replacement
Clinical narrative: Rhabdomyolysis with CK of 65,000 approximately 4 weeks after 2nd COVID 19 vaccination.  Admitted to hospital for 3 days for fluid resuscitation, admitted with abnormal labs to include liver, kidney, urinalysis, and CK.  Labs back to normal within 3 weeks of hospital discharge.  Vaccination Dates:  Dose 1: 30 Dec 2020 Dose 2: 20 Jan 2021
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Liver function test abnormal, Monocyte count increased, Neutrophil count increased, Red blood cell count normal, Renal function test abnormal
Clinical narrative: Rhabdomyolysis with CK of 65,000 approximately 4 weeks after 2nd COVID 19 vaccination.  Admitted to hospital for 3 days for fluid resuscitation, admitted with abnormal labs to include liver, kidney, urinalysis, and CK.  Labs back to normal within 3 weeks of hospital discharge.  Vaccination Dates:  Dose 1: 30 Dec 2020 Dose 2: 20 Jan 2021
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rhabdomyolysis, Urine analysis, White blood cell count increased
Clinical narrative: Rhabdomyolysis with CK of 65,000 approximately 4 weeks after 2nd COVID 19 vaccination.  Admitted to hospital for 3 days for fluid resuscitation, admitted with abnormal labs to include liver, kidney, urinalysis, and CK.  Labs back to normal within 3 weeks of hospital discharge.  Vaccination Dates:  Dose 1: 30 Dec 2020 Dose 2: 20 Jan 2021
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Immune complex assay, Laboratory test, Rash, Rash erythematous
Clinical narrative: 30-year-old after second Pfizer vaccine, developed rash on hand and painful joints. The rash was  erythematous target appearing and painful to touch.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate normal
Clinical narrative: 30-year-old after second Pfizer vaccine, developed rash on hand and painful joints. The rash was  erythematous target appearing and painful to touch.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Immediate post-injection reaction, Incorrect route of product administration, Injection site pain
Clinical narrative: Pt with shoulder pain due to incorrectly placed vaccine. Vaccine needle mark still visible at time of visit, and was injected into the subacromial space of R shoulder rather than the deltoid muscle. Pt had immediate R shoulder pain that has persisted.
Age: 2.0
Sex: M
Vaccine: FLU4
Symptoms: Rash, Swelling face
Clinical narrative: Rash and facial swelling that started the evening of 11/7, worse the next morning. Discontinued amoxicillin when rash started. Rash improved by late morning 11/8
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse event at time of vaccination.  Report submitted due to patient age.  Patient is 16 years old and received Moderna vaccine which is only approved for 18 years of age and older.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administrated, 4 days past expiration date. vaccine expired 11/1/2021. dose administered on 11/5/2021. patient reported no side effects after vaccine
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received vaccine after the 30 day limit in the refrigerator.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Pain, Rash
Clinical narrative: Broke out with stinging rash to my left neck on 10/30/21 - confirmed by Dr as shingles (I had chickenpox as a child but this is my first episode of Shingles), treated last week with Acyclovir.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: only put 0.8 mL of the diluent instead of the required 1.8 mL. Pt received only half diluted dose.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested positive for Covid-19 on 8/12/2021 after being exposed on 8/8/2021 Symptoms of sinus congestion/pressure, ear pain, sore throat started evening of 8/11/2021 monoclonal antibody infusion on 8/17/2021
Age: 65.0
Sex: M
Vaccine: FLU4, PPV
Symptoms: Arthralgia, Injected limb mobility decreased, Injection site pain, Joint range of motion decreased, Joint range of motion measurement
Clinical narrative: about 4 hours after shot given developed severe pain in upper right arm - felt like it was deep in the shoulder joint - had no range of motion whatsoever without intense pain - unable to use arm for 2 days(pain same as 1st day) - took tylenol and ibuprofin but did not help pain - 3rd day pain was less by about 40%-50% with very limited range of motion - 4th day same as 3rd - 5th day pain was better but saw primary care doctor for exam of arm - range of motion better but still feels stiff and more pain when certain motions attempted
Age: 65.0
Sex: M
Vaccine: FLU4, PPV
Symptoms: Musculoskeletal stiffness, Pain
Clinical narrative: about 4 hours after shot given developed severe pain in upper right arm - felt like it was deep in the shoulder joint - had no range of motion whatsoever without intense pain - unable to use arm for 2 days(pain same as 1st day) - took tylenol and ibuprofin but did not help pain - 3rd day pain was less by about 40%-50% with very limited range of motion - 4th day same as 3rd - 5th day pain was better but saw primary care doctor for exam of arm - range of motion better but still feels stiff and more pain when certain motions attempted
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine stored beyond use date given by Moderna.  Moderna ran an analysis and reported: The vaccine administered on October 13, 2021, October 14, 2021 and October 19, 2021 from lot number 020F21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration; however, some vaccine may have activity below the level studied in our clinical trials.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: The nurse came in to get her Pfizer booster. She affirmed that it had been 6 months since her second dose.  She did not have her vaccine card. I have a new coworker who is learning how to check people in. The nurse said she received her second vaccine at the end  of April. I prepared to give her the booster. This was November 4th (Thursday). She was actually working on this day. The dose was to expire at 2:10. She received her dose at 2:01. About the time I gave her the dose, I was told her date was actually May 7th. Which at 30 days per month would have been 26 weeks minus 1 day. After vaccinating her we discovered that her second dose was actually May 28th. We were 21 to 24 days shy of her correct booster dose date.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyskinesia, Feeling hot, Muscle twitching, Neuralgia, Pain
Clinical narrative: Within 12 days or so of the first injection, patient began having severe nerve pain radiating from his spine. His body would involuntary jerk and twitch. He also  had pins and needle sensations in his back. About 6 weeks passed and his symptoms reduced by 80%. So then he received his second Pfizer shot thinking it might be okay. Within 12 days all symptoms were back but worse. He also had a new symptom of sensations of heat on his back and head.  He is about 2 months out from his second shot and the symptoms are still present.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Spinal pain
Clinical narrative: Within 12 days or so of the first injection, patient began having severe nerve pain radiating from his spine. His body would involuntary jerk and twitch. He also  had pins and needle sensations in his back. About 6 weeks passed and his symptoms reduced by 80%. So then he received his second Pfizer shot thinking it might be okay. Within 12 days all symptoms were back but worse. He also had a new symptom of sensations of heat on his back and head.  He is about 2 months out from his second shot and the symptoms are still present.
Age: 6.0
Sex: M
Vaccine: FLUA4
Symptoms: Extra dose administered, Medication error
Clinical narrative: RN BSN gave the student his flu vaccine (authorization signed) 11/05/2021 at 1000. Another RN BSN had preciously reported she checked and that the student had not received his flu vaccine this year. When RN BSN placed the given vaccine into syringe she noted a flu vaccine had already been administered 10/26/2021 in a clinic. RN BSN reports she looked at the wrong patient in prior to releasing the student for his vaccine.